To establish the effectiveness and tolerability of standard of care anti-anginal treatment (beta-blocker and calcium channel blocker medications) in older adults with symptomatic Stable Ischemic Heart Disease (SIHD) and multiple chronic conditions (MCC).
To establish the effectiveness and tolerability of standard of care anti-anginal treatment (beta-blocker and calcium channel blocker medications) in older adults with symptomatic Stable Ischemic Heart Disease (SIHD) and multiple chronic conditions (MCC).
LIVEBETTER: A Trial Comparing Medications in Older Adults With Stable Angina and Multiple Chronic Conditions
-
Yale School of Medicine, New Haven, Connecticut, United States, 06520
Wellstar Research Institute, Marietta, Georgia, United States, 30060
Cook County Health, Chicago, Illinois, United States, 60612
Brigham and Women's Hospital, Boston, Massachusetts, United States, 02115
Mt. Sinai Health System, New York, New York, United States, 10029
NYC Health and Hospitals, Harlem Hospital, New York, New York, United States, 10037-1802
Nirvana Integrative Medicine, New York, New York, United States, 10469
Duke University, School of Medicine, Durham, North Carolina, United States, 27710
Inova Health Care Services, Fairfax, Virginia, United States, 22033
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
65 Years to
ALL
No
Yale University,
Michael Nanna, MD, PRINCIPAL_INVESTIGATOR, Yale University
2027-05-30